Efficacy of a novel online integrated treatment for problem gambling and tobacco smoking: Results of a randomized controlled trial.

cognitive behavioural therapy integrated treatment motivational interviewing online problem gambling self-help tobacco smoking

Journal

Journal of behavioral addictions
ISSN: 2063-5303
Titre abrégé: J Behav Addict
Pays: Hungary
ID NLM: 101602037

Informations de publication

Date de publication:
30 Mar 2023
Historique:
received: 28 04 2022
revised: 02 09 2022
revised: 21 10 2022
accepted: 03 11 2022
medline: 4 4 2023
pubmed: 1 4 2023
entrez: 31 3 2023
Statut: epublish

Résumé

Problem gambling and tobacco use are highly comorbid among adults. However, there are few treatment frameworks that target both gambling and tobacco use simultaneously (i.e., an integrated approach), while also being accessible and evidence-based. The aim of this two-arm open label RCT was to examine the efficacy of an integrated online treatment for problem gambling and tobacco use. A sample of 209 participants (Mage = 37.66, SD = 13.81; 62.2% female) from North America were randomized into one of two treatment conditions (integrated [n = 91] or gambling only [n = 118]) that lasted for eight weeks and consisted of seven online modules. Participants completed assessments at baseline, after treatment completion, and at 24-week follow-up. While a priori planned generalized linear mixed models showed no condition differences on primary (gambling days, money spent, time spent) and secondary outcomes, both conditions did appear to significantly reduce problem gambling and smoking behaviours over time. Post hoc analyses showed that reductions in smoking and gambling craving were correlated with reductions in days spent gambling, as well as with gambling disorder symptoms. Relatively high (versus low) nicotine replacement therapy use was associated with greater reductions in gambling behaviours in the integrated treatment condition. While our open label RCT does not support a clear benefit of integrated treatment, findings suggest that changes in smoking and gambling were correlated over time, regardless of treatment condition, suggesting that more research on mechanisms of smoking outcomes in the context of gambling treatment may be relevant.

Sections du résumé

Background and aims UNASSIGNED
Problem gambling and tobacco use are highly comorbid among adults. However, there are few treatment frameworks that target both gambling and tobacco use simultaneously (i.e., an integrated approach), while also being accessible and evidence-based. The aim of this two-arm open label RCT was to examine the efficacy of an integrated online treatment for problem gambling and tobacco use.
Methods UNASSIGNED
A sample of 209 participants (Mage = 37.66, SD = 13.81; 62.2% female) from North America were randomized into one of two treatment conditions (integrated [n = 91] or gambling only [n = 118]) that lasted for eight weeks and consisted of seven online modules. Participants completed assessments at baseline, after treatment completion, and at 24-week follow-up.
Results UNASSIGNED
While a priori planned generalized linear mixed models showed no condition differences on primary (gambling days, money spent, time spent) and secondary outcomes, both conditions did appear to significantly reduce problem gambling and smoking behaviours over time. Post hoc analyses showed that reductions in smoking and gambling craving were correlated with reductions in days spent gambling, as well as with gambling disorder symptoms. Relatively high (versus low) nicotine replacement therapy use was associated with greater reductions in gambling behaviours in the integrated treatment condition.
Discussion and conclusions UNASSIGNED
While our open label RCT does not support a clear benefit of integrated treatment, findings suggest that changes in smoking and gambling were correlated over time, regardless of treatment condition, suggesting that more research on mechanisms of smoking outcomes in the context of gambling treatment may be relevant.

Identifiants

pubmed: 37000596
doi: 10.1556/2006.2022.00081
pmc: PMC10260216
doi:

Types de publication

Randomized Controlled Trial Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

168-181

Références

Clin Psychol Rev. 2007 Dec;27(8):944-58
pubmed: 17433853
J Consult Clin Psychol. 2001 Feb;69(1):50-7
pubmed: 11302277
Nicotine Tob Res. 2021 Aug 29;23(10):1636-1645
pubmed: 33772298
J Gambl Stud. 2015 Sep;31(3):695-715
pubmed: 24880744
J Gambl Stud. 2015 Mar;31(1):299-313
pubmed: 24065314
Prev Med. 2008 Mar;46(3):181-8
pubmed: 18319098
Subst Use Misuse. 2009;44(7):905-14
pubmed: 19415570
Cogn Behav Ther. 2020 Jul;49(4):327-346
pubmed: 31599198
Cochrane Database Syst Rev. 2012 Nov 14;11:CD008937
pubmed: 23152266
Internet Interv. 2019 Mar 06;17:100239
pubmed: 30906694
Addiction. 1993 Jun;88(6):791-804
pubmed: 8329970
Nicotine Tob Res. 2012 Jul;14(7):833-9
pubmed: 22249688
Drug Alcohol Rev. 2009 Nov;28(6):676-81
pubmed: 19930023
J Consult Clin Psychol. 2006 Jun;74(3):555-67
pubmed: 16822112
J Dual Diagn. 2009 Apr 1;5(2):131-138
pubmed: 20182654
Ann Clin Psychiatry. 2005 Oct-Dec;17(4):237-41
pubmed: 16402757
J Addict Med. 2008;2(4):178-84
pubmed: 19690628
Clin Psychol Rev. 2016 Aug;48:7-31
pubmed: 27372437
Addict Behav. 2013 Aug;38(8):2409-13
pubmed: 23644751
Hum Psychopharmacol. 2006 Jun;21(4):255-63
pubmed: 16783813
Psychiatry Res. 2009 Mar 31;166(1):76-84
pubmed: 19200607
J Clin Psychiatry. 2009 Mar;70(3):334-43
pubmed: 19254518
Addiction. 2002 Jun;97(6):745-53
pubmed: 12084144
Behav Res Ther. 2009 Jul;47(7):592-607
pubmed: 19446287
Aust N Z J Psychiatry. 2015 Jun;49(6):519-39
pubmed: 25735959
Synapse. 2004 Nov;54(2):65-71
pubmed: 15352131
Proc Natl Acad Sci U S A. 1988 Jul;85(14):5274-8
pubmed: 2899326
Ann Clin Psychiatry. 2011 Feb;23(1):3-10
pubmed: 21318190
J Gambl Stud. 2017 Sep;33(3):993-1010
pubmed: 28124288
Psychopharmacology (Berl). 2011 Aug;216(3):305-21
pubmed: 21373791
Br J Addict. 1991 Sep;86(9):1119-27
pubmed: 1932883
Arch Gen Psychiatry. 2004 Nov;61(11):1107-15
pubmed: 15520358
Psychol Addict Behav. 2009 Sep;23(3):512-22
pubmed: 19769435
J Consult Clin Psychol. 2009 Oct;77(5):950-960
pubmed: 19803574
Addict Behav. 1982;7(4):363-71
pubmed: 7183189
JAMA. 1992 Nov 18;268(19):2687-94
pubmed: 1304736
Addict Behav. 2015 Apr;43:72-82
pubmed: 25577724
Can J Psychiatry. 1996 Feb;41(1):36-45
pubmed: 8919422
Addiction. 2011 Mar;106(3):490-8
pubmed: 21210880
Nature. 1996 Jul 18;382(6588):255-7
pubmed: 8717040
Clin Psychol Rev. 2021 Nov;89:102083
pubmed: 34536796
Am J Addict. 2004 Oct-Dec;13(5):471-93
pubmed: 15764425
J Med Internet Res. 2013 Aug 30;15(8):e162
pubmed: 23996958
Trials. 2020 Nov 19;21(1):937
pubmed: 33213506
J Stud Alcohol Drugs. 2012 Sep;73(5):829-33
pubmed: 22846247
Internet Interv. 2020 Jan 18;19:100307
pubmed: 32042600

Auteurs

Van Bui (V)

1Department of Psychology, University of Manitoba, Canada.

Christian Baumgartner (C)

2Swiss Research Institute for Public Health and Addiction, University of Zurich, Switzerland.

Elena Bilevicius (E)

1Department of Psychology, University of Manitoba, Canada.

Alanna Single (A)

1Department of Psychology, University of Manitoba, Canada.

Lana Vedelago (L)

3Department of Psychology, York University, Canada.

Vanessa Morris (V)

14Department of Psychology, University of New Brunswick, Canada.

Tyler Kempe (T)

1Department of Psychology, University of Manitoba, Canada.

Michael P Schaub (MP)

2Swiss Research Institute for Public Health and Addiction, University of Zurich, Switzerland.

Sherry H Stewart (SH)

4Departments of Psychiatry and Psychology & Neuroscience, Dalhousie University, Canada.

James MacKillop (J)

5Peter Boris Centre for Addictions Research McMaster University/St. Joseph's Healthcare Hamilton, Canada.

David C Hodgins (DC)

6Department of Psychology, University of Calgary, Canada.

Jeffrey D Wardell (JD)

3Department of Psychology, York University, Canada.
12Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Canada.
13Department of Psychiatry, University of Toronto, Canada.

Rosin O'Connor (R)

7Department of Psychology, Concordia University, Canada.

Jennifer Read (J)

8Department of Psychology, University of Buffalo, USA.

Heather D Hadjistavropoulos (HD)

9Department of Psychology, University of Regina, Canada.

Christopher Sundström (C)

10Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.

Sarah Dermody (S)

11Department of Psychology, Ryerson University, Canada.

Andrew H Kim (AH)

11Department of Psychology, Ryerson University, Canada.

Matthew T Keough (MT)

1Department of Psychology, University of Manitoba, Canada.
3Department of Psychology, York University, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH